Perspective Therapeutics (CATX) Stock Price Target 2026

The average analyst price target for Perspective Therapeutics is $12.19, 1359.2% above the current price. Of 15 analysts, 13 rate it Buy and 2 Hold. Targets range from $4 to $22. The latest change came on Oct 26, 2026, when RBC Capital downgraded Perspective Therapeutics from Outperform to Sector Perform and moved its price target from $14 to $4.